Focal cortical dysplasias: modeling pediatric drug-resistant epilepsy using human brain organoids. [PDF]
Petralla S +8 more
europepmc +1 more source
High frequency deep brain stimulation of the hippocampus in a rat model for temporal lobe epilepsy [PDF]
Boon, Paul +9 more
core +1 more source
Rhythms in longitudinal thalamic recordings are linked to seizure risk
Abstract Objective Seizure unpredictability remains a major clinical challenge for people with epilepsy. Previous works have shown that seizure risk is associated with circadian and multi‐day cycles in both brain and physiological signals. However, it remains unclear whether neural activity from deep brain structures such as the anterior nucleus of the
Xinbing Zhang +5 more
wiley +1 more source
Clioquinol "<i>Sweetens the Pot</i>" for Drug-Resistant Epilepsy-With an After Taste. [PDF]
Scharfman HE.
europepmc +1 more source
Abstract Objective This study was undertaken to investigate the molecular consequences of pathogenic variants in the SMC1A gene—particularly those associated with developmental and epileptic encephalopathy (DEE85)—and to evaluate the therapeutic potential of ataluren in restoring SMC1A function and mitigating disease‐related transcriptomic and genomic ...
Maddalena Di Nardo +7 more
wiley +1 more source
Efficacy and safety of adjunctive clobazam in Chinese patients with drug-resistant epilepsy: a single-center real-world study. [PDF]
Zhang Y +6 more
europepmc +1 more source
Abstract Objective The latest European Medicines Agency (EMA) guideline on the clinical investigation of medicines to treat epileptic disorders was adopted by the EMA Committee for Medicinal Products for Human Use in 2025. We compared this guideline with the previous version (2010), highlighting areas where significant revisions were introduced ...
Stéphane Auvin +7 more
wiley +1 more source
Locating the epileptogenic zone for drug-resistant epilepsy through neuroelectrophysiological brain network topology. [PDF]
Zhang W +8 more
europepmc +1 more source
Abstract Objective This study was undertaken to present the results of an exploratory phase 2 trial of stiripentol in Lennox–Gastaut syndrome (LGS). Methods This exploratory single‐blind, single‐arm, nonrandomized sequential‐period phase 2 study was conducted at four centers in France between January 1989 and August 1993.
Stéphane Auvin +3 more
wiley +1 more source
Real-world outcomes of ketogenic diet therapy in children with drug-resistant epilepsy in a prospective cohort study. [PDF]
Han R +14 more
europepmc +1 more source

